Explainable AI reveals changes in skin microbiome composition linked to phenotypic differences.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 02 2021
Historique:
received: 14 10 2020
accepted: 08 02 2021
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 15 12 2021
Statut: epublish

Résumé

Alterations in the human microbiome have been observed in a variety of conditions such as asthma, gingivitis, dermatitis and cancer, and much remains to be learned about the links between the microbiome and human health. The fusion of artificial intelligence with rich microbiome datasets can offer an improved understanding of the microbiome's role in human health. To gain actionable insights it is essential to consider both the predictive power and the transparency of the models by providing explanations for the predictions. We combine the collection of leg skin microbiome samples from two healthy cohorts of women with the application of an explainable artificial intelligence (EAI) approach that provides accurate predictions of phenotypes with explanations. The explanations are expressed in terms of variations in the relative abundance of key microbes that drive the predictions. We predict skin hydration, subject's age, pre/post-menopausal status and smoking status from the leg skin microbiome. The changes in microbial composition linked to skin hydration can accelerate the development of personalized treatments for healthy skin, while those associated with age may offer insights into the skin aging process. The leg microbiome signatures associated with smoking and menopausal status are consistent with previous findings from oral/respiratory tract microbiomes and vaginal/gut microbiomes respectively. This suggests that easily accessible microbiome samples could be used to investigate health-related phenotypes, offering potential for non-invasive diagnosis and condition monitoring. Our EAI approach sets the stage for new work focused on understanding the complex relationships between microbial communities and phenotypes. Our approach can be applied to predict any condition from microbiome samples and has the potential to accelerate the development of microbiome-based personalized therapeutics and non-invasive diagnostics.

Identifiants

pubmed: 33633172
doi: 10.1038/s41598-021-83922-6
pii: 10.1038/s41598-021-83922-6
pmc: PMC7907326
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4565

Références

PLoS One. 2010 Dec 20;5(12):e15216
pubmed: 21188149
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Science. 2009 May 29;324(5931):1190-2
pubmed: 19478181
Am J Clin Dermatol. 2003;4(6):371-8
pubmed: 12762829
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22071-22080
pubmed: 31619572
PLoS Comput Biol. 2016 Jul 11;12(7):e1004977
pubmed: 27400279
mSystems. 2019 Jan 29;4(1):
pubmed: 30701193
BMC Bioinformatics. 2012 Feb 14;13:31
pubmed: 22333067
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
BMC Biol. 2019 Jun 12;17(1):47
pubmed: 31189482
Front Genet. 2019 Jun 25;10:579
pubmed: 31293616
Appl Microbiol Biotechnol. 2020 Jul;104(14):6287-6297
pubmed: 32448997
Sci Rep. 2016 Oct 27;6:36062
pubmed: 27786295
Nat Rev Microbiol. 2018 Mar;16(3):143-155
pubmed: 29332945
Inflamm Bowel Dis. 2016 Sep;22(9):2070-7
pubmed: 27542127
PLoS One. 2016 Nov 3;11(11):e0166026
pubmed: 27812181
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
J Invest Dermatol. 1965 Dec;45(6):498-503
pubmed: 5321315
J Invest Dermatol. 2013 Sep;133(9):2152-60
pubmed: 23337890
Folia Microbiol (Praha). 2014 Nov;59(6):495-502
pubmed: 24880250
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2038-2047
pubmed: 27735094
Bioinformatics. 2018 Jul 1;34(13):i32-i42
pubmed: 29950008
Sci Rep. 2017 Sep 5;7(1):10567
pubmed: 28874721
PLoS One. 2013 Sep 04;8(9):e73056
pubmed: 24023808
Nat Microbiol. 2016 Jul 11;1(9):16106
pubmed: 27562258
J Microbiol Biotechnol. 2015 Dec 28;25(12):2160-8
pubmed: 26428734
Nat Rev Microbiol. 2019 Jul;17(7):399
pubmed: 31089291
Cell Host Microbe. 2017 Jan 11;21(1):97-105
pubmed: 28017660
New Microbes New Infect. 2017 Jul 23;19:134-136
pubmed: 28831302
J Invest Dermatol. 2019 Dec;139(12):2497-2505.e6
pubmed: 31420081
Genome Biol. 2019 Sep 2;20(1):186
pubmed: 31477162
Menopause. 2014 May;21(5):450-8
pubmed: 24080849
PLoS One. 2008 Jul 23;3(7):e2719
pubmed: 18648509
Sci Rep. 2019 Nov 14;9(1):16748
pubmed: 31727980
FEBS Lett. 2019 Sep;593(18):2655-2664
pubmed: 31273779
Trends Mol Med. 2015 Aug;21(8):461-2
pubmed: 26129865
Microbiome. 2019 Mar 16;7(1):40
pubmed: 30878035
Acta Derm Venereol. 2020 Sep 30;100(16):adv00273
pubmed: 32852562
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491-502
pubmed: 28611480
Nat Rev Microbiol. 2011 Apr;9(4):244-53
pubmed: 21407241
J Oral Microbiol. 2015 Sep 29;7:28934
pubmed: 26426306
Genome Res. 2012 May;22(5):850-9
pubmed: 22310478
Respir Res. 2018 Dec 14;19(1):253
pubmed: 30547792
PLoS One. 2013;8(3):e59260
pubmed: 23516617
Inflamm Bowel Dis. 2014 Sep;20(9):1496-501
pubmed: 25072500
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Cell Host Microbe. 2011 Oct 20;10(4):292-6
pubmed: 22018228
Gigascience. 2020 Mar 1;9(3):
pubmed: 32150601
Sci Rep. 2013;3:2620
pubmed: 24018484
Nature. 2018 Nov;563(7732):S91-S93
pubmed: 30464283
Nature. 2013 Jun 6;498(7452):99-103
pubmed: 23719380
Nature. 2014 Oct 2;514(7520):59-64
pubmed: 25279917
J Invest Dermatol. 1985 Nov;85(5):483-5
pubmed: 4056460

Auteurs

Anna Paola Carrieri (AP)

The Hartree Centre, Sci-Tech Daresbury, IBM Research, Daresbury, WA4 4AD, UK. acarrieri@uk.ibm.com.

Niina Haiminen (N)

T.J. Watson Research Center, IBM Research, Yorktown Heights, NY, 10598, USA.

Sean Maudsley-Barton (S)

The Hartree Centre, Sci-Tech Daresbury, IBM Research, Daresbury, WA4 4AD, UK.
Department of Computing and Mathematics, Manchester Metropolitan University (MUU), Manchester, M15 6BH, UK.

Laura-Jayne Gardiner (LJ)

The Hartree Centre, Sci-Tech Daresbury, IBM Research, Daresbury, WA4 4AD, UK.

Barry Murphy (B)

Unilever Research & Development, Port Sunlight, CH63 3JW, UK.

Andrew E Mayes (AE)

Unilever Research and Development, Sharnbrook, MK44 1LQ, UK.

Sarah Paterson (S)

Unilever Research & Development, Port Sunlight, CH63 3JW, UK.

Sally Grimshaw (S)

Unilever Research & Development, Port Sunlight, CH63 3JW, UK.

Martyn Winn (M)

Scientific Computing Department, STFC Daresbury Lab, Daresbury, WA4 4AD, UK.

Cameron Shand (C)

The Hartree Centre, Sci-Tech Daresbury, IBM Research, Daresbury, WA4 4AD, UK.
Department of Computer Science, University of Manchester (UoM), Manchester, M13 9LP, UK.

Panagiotis Hadjidoukas (P)

IBM Research - Zurich, Saumerstrasse 4, 8803, Rueschlikon, Switzerland.

Will P M Rowe (WPM)

University of Birmingham, Birmingham, UK.

Stacy Hawkins (S)

Unilever Research & Development, Trumbull, CT, 06611, USA.

Ashley MacGuire-Flanagan (A)

Unilever Research & Development, Trumbull, CT, 06611, USA.

Jane Tazzioli (J)

Unilever Research & Development, Trumbull, CT, 06611, USA.

John G Kenny (JG)

Institute of Integrative Biology, The University of Liverpool, The Bioscience Building, Liverpool, L697ZB, UK.

Laxmi Parida (L)

T.J. Watson Research Center, IBM Research, Yorktown Heights, NY, 10598, USA.

Michael Hoptroff (M)

Unilever Research & Development, Port Sunlight, CH63 3JW, UK.

Edward O Pyzer-Knapp (EO)

The Hartree Centre, Sci-Tech Daresbury, IBM Research, Daresbury, WA4 4AD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH